Curiox Biosystems

Beta

KRX Filings & Disclosures 2026

Risk Factors

• • Put option on KRW 20B convertible bonds exercisable quarterly from July 26, 2026, at 100% principal amount
• • Call option on up to 20% of bonds at principal + 1% annual compounded interest, exercisable daily from July 26, 2025 to July 26, 2026

Business Overview

• • Cell and gene therapy (CGT) focus in single-cell transcriptome and epitope indexing via CITE-Seq technology
• • DropArray™ platform utilizing laminar flow wash (Laminar Wash™) introduced for non-disruptive cell cleaning

Management Discussion & Analysis

• • Revenue KRW 5,152M in 2025, up 12.29% YoY; operating loss KRW 12,314M, reduced by 7.95% from prior year; net loss KRW 27,178M, wider by KRW 19,089M
• • Pluto Wash new product portfolio drove revenue increase with KRW 313M product sales growth and KRW 251M from new installations

What are the latest Curiox Biosystems DART filings in 2026?

Curiox Biosystems (KRX code 445680) has filed an annual report on March 23, 2026 with DART. SignalX tracks every new DART disclosure with AI-powered English summaries of business overview, risk factors, and management discussion.

When did Curiox Biosystems file its most recent annual report?

Curiox Biosystems filed its most recent annual report on March 23, 2026. The annual report includes audited financial statements, business overview, risk factors, and management discussion (MD&A), all available on SignalX with AI-generated English summaries and KIFRS financial data.

What is Curiox Biosystems's KRX stock code?

Curiox Biosystems's KRX stock code is 445680. The 6-digit stock code is the KRX standard identifier for every listed security. You can use stock code 445680 to look up all Curiox Biosystems disclosures on DART, or browse them here on SignalX with AI-powered English analysis.

How often does Curiox Biosystems file with DART?

Korean listed companies file an annual report once per year (typically within 90 days of fiscal year-end), a half-year report once mid-year, and quarterly reports for Q1 and Q3 — three regular periodic disclosures plus the annual. Material event reports are filed as needed when corporate events occur. SignalX monitors DART daily.

What is the difference between annual, half-year, and quarterly reports in Korea?

An annual report is a comprehensive filing with audited financials, business overview, and risk factors — analogous to the US 10-K. A half-year (interim) report covers H1 results. Quarterly reports cover Q1 or Q3 — analogous to the US 10-Q but Korea publishes only two quarterly reports per year (with the half-year report covering Q2). SignalX provides AI-generated English summaries for all three filing types for Curiox Biosystems.

Where can I find Curiox Biosystems financial data and KIFRS metrics?

SignalX extracts KIFRS consolidated financial data from Curiox Biosystems annual reports, including revenue, gross profit, operating income, net income, total assets, stockholders' equity, EPS (basic/diluted), operating cash flow, and capital expenditure — all in KRW. Multi-year financial trends are displayed in the Financial Summary table above.